Skip to main content
Veterinary Medicines

Biocan Novel DHPPi/L4R, Lyophilisate and solvent for suspension for injection

Awtorizzat
  • Canine distemper virus, strain CDV Bio 11/A, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine parvovirus 2b, strain CPV-2b Bio 12/B, Live
  • Canine parainfluenza virus 2, strain CPiV-2-Bio 15, Live
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1090, Inactivated
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
  • Leptospira interrogans, serogroup Australis, serovar Bratislava, Inactivated
  • Leptospira kirschneri, Serogroup Grippotyphosa, Inactivated

Identifikazzjoni tal-prodott

Isem tal-mediċina:
Biocan Novel DHPPi/L4R, Lyophilisate and solvent for suspension for injection
Biocan Novel DHPPi/L4R vakcina A.U.V.
Sustanza attiva:
Metodu ta’ amministrazzjoni:
  • Użu għal taħt il-ġilda

Dettalji tal-prodott

Sustanza attiva / Qawwa:
  • Disponibbli biss fi English
    5.10
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
  • Disponibbli biss fi English
    5.30
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
  • Disponibbli biss fi English
    6.60
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
  • Disponibbli biss fi English
    5.10
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
  • Disponibbli biss fi English
    51.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Disponibbli biss fi English
    51.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Disponibbli biss fi English
    2.00
    international unit(s)
    /
    1.00
    Dose
  • Disponibbli biss fi English
    51.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Disponibbli biss fi English
    40.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
Withdrawal period by route of administration:
  • Użu għal taħt il-ġilda
    • Dog
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
  • QI07AJ06
Status tal-awtorizzazzjoni:
  • Valid
Deskrizzjoni tal-pakkett:

Tagħrif addizzjonali

Entitlement type:
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
  • Bioveta a.s.
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
  • Bioveta a.s.
Awtorità responsabbli:
  • European Medicines Agency
Numru tal-awtorizzazzjoni:
  • 3546/X/14 NÉBIH ÁTI
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
Numru tal-proċedura:
  • CZ/V/0119/001
Kemm kienet utli din il-paġna?:
No votes yet
Jekk jogħġbok ma tinkludix data personali, bħal ismek jew dettalji ta' kuntatt. Jekk tagħmel dan, tagħti l-kunsens tagħha għall-ipproċessar ta’ dik id-dejta skont id-Dikjarazzjoni ta’ Privatezza tal-EMA dwar talbiet għal informazzjoni jew aċċess għal dokumenti. Jekk tixtieq tweġiba mill-EMA, jekk jogħġbok Ibgħat mistoqsija lill-EMA minflok.